Table 1.
Characteristics of male MESA participants by completion of the International Consultation on Incontinence Questionnaire (ICIQ), 2015–2016
| Completed ICIQ (n=1446) | Did not complete ICIQ (n=90) | P value | |
|---|---|---|---|
| Age, mean (SD), y | 73.7 (8.4) | 81.0 (9.2) | <0.001 |
| Age Categories, (%) | <0.001 | ||
| 55–64 y | 15.3 | 5.6 | |
| 65–74 y | 41.6 | 18.9 | |
| 75–84 y | 31.0 | 43.3 | |
| >= 85 y | 11.9 | 32.2 | |
| Race/ethnicity (%) | 0.05 | ||
| Non-Hispanic White | 40.7 | 41.1 | |
| Chinese | 14.2 | 4.4 | |
| Non-Hispanic Black | 22.9 | 28.9 | |
| Hispanic | 22.1 | 25.6 | |
| BMI, kg/m2 (SD) | 28.2 (4.8) | 26.7 (5.2) | 0.004 |
| Obese (%) | 31.9 | 22.4 | 0.2 |
| Diabetes and 2003 ADA Fasting criteria (%) | 0.35 | ||
| Impaired fasting | 26.3 | 18.3 | |
| Diabetes mellitus | 26.5 | 35 | |
| General Health, (%) | <0.01 | ||
| Excellent | 14.2 | 6.7 | |
| Very Good | 36.2 | 27 | |
| Good | 35.7 | 40.4 | |
| Fair | 12.7 | 16.8 | |
| Poor | 1.1 | 9 | |
| Any Diuretic use, (%) | 16.9 | 23.3 | 0.1 |
| Current Cigarette Use, (%) | 6 | 2.3 | 0.01 |
| Prostate cancer, (%) | 1.3 | 0 | 0.3 |
| Any Calcium channel blockers use, (%) | 21.9 | 27.8 | 0.2 |
| Alpha Blockers use, (%) | 4.1 | 5.6 | 0.5 |
| Beta blockers, (%) | 22.8 | 33.3 | 0.02 |